Hudson Valley Investment Advisors Inc Moderna, Inc. Transaction History

Hudson Valley Investment Advisors Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$126.46 - $235.05 $3.53 Million - $6.55 Million	-27,881 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$225.82 - $368.51 $6.17 Million - $10.1 Million	27,326 Added 4923.6%	27,881 $1.85 Million
Q3 2021 Oct 26, 2021	BUY	$221.9 - $484.47 $123,154 - $268,880	555 New	555 $214,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hudson Valley Investment Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Hudson Valley Investment Advisors Inc with notifications on news.